Skip to search.
 FTSE 100 Down 0.04%

Rockwell Medical, Inc. (RMTI)

-NasdaqGM
10.00 Down 1.13(10.15%) 27 Feb 21:00
|After Hours: : 10.04 Up 0.04 (0.40%) 27 Feb 23:34
Add to Portfolio
Prev Close:11.13
Open:10.42
Bid:N/A
Ask:13.88 x 600
1y Target Est:18.86
Beta:1.64
Earnings Date:11 May - 15 May (Est.)
Day's Range:9.99 - 10.85
52wk Range:8.10 - 14.80
Volume:2,069,294
Avg Vol (3m):963,308
Market Cap:502.84m
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for RMTI at this time.

Comparison

Symbol% ChgMkt Cap
RMTIDown 10.15%502.84m
FMSUp 2.10%24.71b
SNYDown 0.02%128.58b

Key Statistics

Forward P/E (1 yr):7.30
P/S (ttm):10.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.32
Quarterly EPS Est (Mar-15) :-0.04
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.50

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secon... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback